Pfizer announced that its board of directors declared an increase in the quarterly cash dividend on the company’s common stock to 41c for the first-quarter 2023 dividend, payable March 3, 2023, to holders of the Common Stock of record at the close of business on January 27, 2023. "Our ability to increase our dividend is a testament to our solid financial performance during 2022. This increase reinforces Pfizer’s commitment of returning value to our shareholders," said Dr. Albert Bourla, Pfizer Chairman and CEO.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on PFE:
- Pfizer, BioNTech get FDA FTD for mRNA-based combination vaccine candidate
- Pfizer, BioNTech announce EUA for bivalent COVID vaccine for children under 5
- Two “Perfect 10” Healthcare Stocks to Beat the Market
- #SocialStocks: EU rules against Meta, despite attempts to settle
- Prometheus price target raised to $114 from $67 at Piper Sandler
